Sign in

CIK 0001385818

  • Non-accelerated filer
  • Smaller reporting company

AYTU BIOPHARMA, INC

Sign in to watch
Ticker
AYTU
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Jun 30
Incorporated
DE
Entity type
Operating
EIN
470883144
Phone
+1 720-437-6580
Business address
7900 E. UNION AVENUE, SUITE 920, DENVER, CO, 80237
Former names
AYTU BIOSCIENCE, INC, Rosewind CORP
  1. 4 Exercise or conversion Chief Financial Officer acquired 66,666 shares (option exercise)
  2. 4 Exercise or conversion Director acquired 416,667 shares (option exercise)
  3. 4 Exercise or conversion Director acquired 37,083 shares (option exercise)
  4. 4 Exercise or conversion Chief Operating Officer acquired 187,500 shares (option exercise)
  5. 4 Exercise or conversion Chief Executive Officer acquired 187,500 shares (option exercise)
  6. 4 Derivatives Options or other derivatives
  7. 4 Open-market buy Director bought 33,333 shares at $1.50 ($50,000)
  8. 4 Open-market buy Chief Financial Officer bought 66,666 shares at $1.50 ($99,999)
  9. 4 Open-market buy Chief Operating Officer bought 166,666 shares at $1.50 ($249,999)
  10. 4 Open-market buy Chief Executive Officer bought 166,666 shares at $1.50 ($249,999)
  11. 4/A Derivatives Options or other derivatives
  12. 4/A Derivatives Options or other derivatives
  13. 4/A Derivatives Options or other derivatives
  14. 3/A Insider 3/A
  15. 4 Grant or award Chief Financial Officer acquired 41,899 shares (grant or award)
  16. 4 Grant or award Chief Executive Officer acquired 52,374 shares (grant or award)
  17. 4 Grant or award Chief Operating Officer acquired 48,184 shares (grant or award)
  18. 4 Grant or award Director acquired 65,000 shares (grant or award)
  19. 3 Insider Initial Statement of Ownership
  20. 4 Grant or award Director acquired 65,000 shares (grant or award)

Page 8 of 10 · 187 filings